Both in Pharmaceuticals
Dyne Therapeutics vs Viridian Therapeutics
Over the past year DYN returned −30.1% and VRDN returned +4.7%; their daily moves had a correlation of 0.24.
DYN −30.1% VRDN +4.7%Growth of $1, one year, split-adjusted
| Metric | DYN | VRDN |
|---|---|---|
| Price | $16.98 | $24.27 |
| Market cap | $3.17B | $2.75B |
| Today | +0.24% | +0.75% |
| 1 month | +4.8% | +21.4% |
| 6 months | −2.5% | +82.5% |
| Year to date | −13.2% | −22.0% |
| 1 year | −29.7% | +7.7% |
| Revenue growth (YoY) | — | +278.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −39726.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 38.7× |
| Net cash | $685.0M | $625.7M |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | 49.8% |
| Short % of float | 14.6% | 18.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).